Fusion Pharmaceuticals Inc (FUSN)
$0.00 $0.00 (0.00%) 4:38 PM 12/12/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$1.83B -
Day's Range
- - - -
Volume
- -
52 Week Low / High
$4.78 - $21.60 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
FUSN's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 0
- Buy
- 11
- Hold
- 0
- Sell
- 0
- Strong Sell
- $13.10
- Target Price
Company News
-
Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement — May 31st, 2024
HAMILTON, ON and BOSTON, May 31, 2024 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, today announced it has obtained a final order from the Ontario Superior ...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$